What Agios Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 3 | 42 |
| Total trades | 5 | 93 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 1,989 | 306,008 |
| Disposed | 31,989 | 152,488 |
| Net activity | −30,000 | +153,520 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Gheuens Sarah | Chief Medical Officer | Oct 22 | Open-market sale · S | −500 | $37.52 | −$18.8K | 54,645 |
| Gheuens Sarah | Chief Medical Officer | Oct 22 | Exercise / conversion · M | +500 | $25.01 | +$12.5K | 55,145 |
| Gheuens Sarah | Chief Medical Officer | Oct 21 | Open-market sale · S | −1,489 | $37.53 | −$55.9K | 54,645 |
| Gheuens Sarah | Chief Medical Officer | Oct 21 | Exercise / conversion · M | +1,489 | $25.01 | +$37.2K | 56,134 |
| Gheuens Sarah | Chief Medical Officer | Aug 04 | Open-market sale · S | −30,000 | $30.48 | −$914K | 54,645 |
| Backstrom Jay T. | Director | Jul 08 | Grant / award · A | +1,447 | — | — | 1,447 |
| Gheuens Sarah | Chief Medical Officer | Jul 01 | Open-market sale · S | −4,007 | $37.56 | −$151K | 84,645 |
| Gheuens Sarah | Chief Medical Officer | Jul 01 | Exercise / conversion · M | +8,375 | — | — | 88,652 |
| Smith Cynthia | Director | Jun 18 | Exercise / conversion · M | +2,816 | — | — | 15,230 |
| Owen Catherine E. | Director | Jun 18 | Exercise / conversion · M | +2,816 | — | — | 10,865 |
| Scadden David | Director | Jun 18 | Exercise / conversion · M | +2,816 | — | — | 20,419 |
| Ho Maykin | Director | Jun 18 | Exercise / conversion · M | +2,816 | — | — | 19,848 |
| Foster-Cheek Kaye I | Director | Jun 18 | Exercise / conversion · M | +2,816 | — | — | 10,284 |
| Fouse Jacqualyn A | Director | Jun 18 | Exercise / conversion · M | +2,816 | — | — | 154,156 |
| Ballal Rahul D. | Director | Jun 18 | Exercise / conversion · M | +2,816 | — | — | 15,230 |
| Capello Jeffrey D | Director | Jun 18 | Exercise / conversion · M | +2,816 | — | — | 10,865 |
| Owen Catherine E. | Director | Jun 13 | Exercise / conversion · M | +1,976 | — | — | 8,049 |
| Capello Jeffrey D | Director | Jun 13 | Exercise / conversion · M | +1,976 | — | — | 8,049 |
| Viswanadhan Krishnan | Chief Corp Dev & Strategy | Apr 02 | Open-market sale · S | −2,959 | $34.71 | −$103K | 10,282 |
| Viswanadhan Krishnan | Chief Corp Dev & Strategy | Apr 02 | Exercise / conversion · M | +8,100 | — | — | 13,241 |
Loading...
